1. Home
  2. LEGN vs VIST Comparison

LEGN vs VIST Comparison

Compare LEGN & VIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • VIST
  • Stock Information
  • Founded
  • LEGN 2014
  • VIST 2017
  • Country
  • LEGN United States
  • VIST Mexico
  • Employees
  • LEGN N/A
  • VIST N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • VIST Oil & Gas Production
  • Sector
  • LEGN Health Care
  • VIST Energy
  • Exchange
  • LEGN Nasdaq
  • VIST Nasdaq
  • Market Cap
  • LEGN 6.3B
  • VIST 5.1B
  • IPO Year
  • LEGN 2020
  • VIST 2019
  • Fundamental
  • Price
  • LEGN $31.46
  • VIST $34.34
  • Analyst Decision
  • LEGN Strong Buy
  • VIST Buy
  • Analyst Count
  • LEGN 12
  • VIST 3
  • Target Price
  • LEGN $73.36
  • VIST $65.00
  • AVG Volume (30 Days)
  • LEGN 1.2M
  • VIST 1.4M
  • Earning Date
  • LEGN 11-11-2025
  • VIST 10-22-2025
  • Dividend Yield
  • LEGN N/A
  • VIST N/A
  • EPS Growth
  • LEGN N/A
  • VIST 26.19
  • EPS
  • LEGN N/A
  • VIST 5.47
  • Revenue
  • LEGN $796,838,000.00
  • VIST $1,982,699,000.00
  • Revenue This Year
  • LEGN $69.31
  • VIST $38.98
  • Revenue Next Year
  • LEGN $52.73
  • VIST $18.03
  • P/E Ratio
  • LEGN N/A
  • VIST $6.42
  • Revenue Growth
  • LEGN 74.75
  • VIST 49.52
  • 52 Week Low
  • LEGN $27.34
  • VIST $31.63
  • 52 Week High
  • LEGN $51.77
  • VIST $61.67
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 31.45
  • VIST 38.77
  • Support Level
  • LEGN $32.02
  • VIST $33.45
  • Resistance Level
  • LEGN $32.62
  • VIST $38.41
  • Average True Range (ATR)
  • LEGN 1.02
  • VIST 1.65
  • MACD
  • LEGN -0.09
  • VIST 0.10
  • Stochastic Oscillator
  • LEGN 6.87
  • VIST 12.14

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About VIST Vista Energy S.A.B. de C.V. each representing one series A share with no par value

Vista Energy SAB de CV is an independent oil and gas company. It is focused on shale oil and shale gas exploration at its main assets in Vaca Muerta. The company has operations in Argentina and Mexico. The company operates in a single segment- the exploration and production of Crude oil, Natural gas, and LPG. Geographically, It operates in Argentina and Mexico. it generates the majority of its revenue from Argentina.

Share on Social Networks: